Novel biomarker has potential for predicting and treating skin cancer metastasis

by

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *